CALEE HOCHSTEDLER: Open Payments
NPI 1619620812 · GREENFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 95 payments from 30 companies in 2025. Trend: 2023 $1,337 · 2024 $1,338 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $290 |
| Merck Sharp & Dohme LLC | 11 | $237 |
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| Daiichi Sankyo Inc. | 9 | $162 |
| Exelixis Inc. | 4 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Genentech USA, Inc. | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $67 |
| PFIZER INC. | 3 | $61 |
Products named: KEYTRUDA, KISQALI, ENHERTU, CABOMETYX, DATROWAY, SCEMBLIX, LIBTAYO, ELREXFIO.
Industry payments across IN — which companies pay providers there.
